Skip to main content
. 2022 Nov 15;14(11):7632–7642.

Table 2.

Incidence of adverse reactions

Study Adverse reaction

E C
Zhu W 2020 [11] Vaginal pain 1 case Vaginal pain 1 case, pruritus 1 case, fever 1 case
Shun X 2022 [15] Abdominal distension 3 cases, pruritus 2 cases, vaginal pain 2 cases Abdominal distension 3 cases, pruritus 3 cases, vaginal pain 2 cases
Li C 2018 [16] Vaginal uncomfortable 4 cases, fever 3 cases, urine frequency 2 cases Vaginal uncomfortable 5 cases, fever 3 cases, urine frequency 3 cases
Liu H 2016 [17] Irritability 1 case Irritability 1 case, gastrointestinal reaction 1 case
Lai Z 2021 [18] Vaginal pain 3 cases, vaginal dryness 2 cases Vaginal pain 1 case, vaginal dryness 3 cases
Li X 2020 [19] leucorrhea increasing 1 case, rash 1 case leucorrhea increasing 2 cases, rash 1 case
Wang L 2021 [20] Vaginal secretion increase 1 case, abnormal leukorrhea 2 cases, vaginal uncomfortable 2 cases Vaginal secretion increase 3 cases, abnormal leukorrhea 4 cases, vaginal uncomfortable 6 cases
Lai X 2022 [21] Vaginal uncomfortable 1 case, fever 1 case Vaginal uncomfortable 3 cases, fever 2 cases, urine frequency 1 case
Yi B 2021 [22] Vaginal pain 5 cases, abdominal distension 2 cases, vaginal secretion increase 1 case Vaginal pain 3cases, abdominal distension 2 cases, vaginal uncomfortable 1 case, vaginal secretion increase 1 case
Zhou J 2020 [23] Pruritus 1 case Vaginal pain 2 cases, pruritus 3 cases, urine frequency 3 cases

E: experimental group; C: control group.